The association between leptin and insulin levels in adults with cystic fibrosis

Diabetes and Metabolism

Volumn 38, Issue 1, 2012, Pages 34-39

  Ziai, S ^a,c   Belson, L ^a,c   Malet, A ^d   Tardif, A ^b,c   Berthiaume, Y ^d,e   Coderre, L ^a,c,e   Rabasa Lhoret, R ^a,b,c,d,e  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Montreal Diabetes Research Centre (MDRC)   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cystic fibrosis; Cystic fibrosis related diabetes; Insulin; Leptin

Indexed keywords

FIBRINOGEN; GLUCOSE; INSULIN; LEPTIN;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CYSTIC FIBROSIS; ENERGY BALANCE; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; LEPTIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; WEIGHT GAIN;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CANADA; COHORT STUDIES; CYSTIC FIBROSIS; DIABETES MELLITUS; FASTING; FEMALE; FIBRINOGEN; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; PROSPECTIVE STUDIES;

EID: 84856723081     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.07.003     Document Type: Article

References (25)

1. Anderson P. Emerging therapies in cystic fibrosis. Ther Adv Respir Dis 2010, 4:177-185.
2. Ntimbane T., Comte B., Mailhot G., Berthiaume Y., Poitout V., Prentki M., et al. Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. Clin Biochem Rev 2009, 30:153-177.
3. Costa M., Potvin S., Berthiaume Y., Gauthier L., Jeanneret A., Lavoie A., et al. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes Metab 2005, 31(3 Pt 1):221-232.
4. Lands L.C., Iskandar M., Beaudoin N., Meehan B., Dauletbaev N., Berthiuame Y. Dietary supplementation with pressurized whey in patients with cystic fibrosis. J Med Food 2010, 13:77-82.
5. Hardin D.S. A review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth. Horm Res 2007, 68(Suppl. 5):113-116.
6. Stephenson A. Canadian cystic fibrosis patient statistics. Canadian Cystic Fibrosis Foundation Online: [Updated 2010/02/17, Cited 2010/09/20]. Available from: http://www.cysticfibrosis.ca/en/publications/CanadianCFPatientStatistics.php.
7. Nathan B.M., Laguna T., Moran A. Recent trends in cystic fibrosis-related diabetes. Curr Opin Endocrinol Diabetes Obes 2010, 17:335-341.
8. Costa M., Potvin S., Hammana I., Malet A., Berthiaume Y., Jeanneret A., et al. Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 2007, 6:376-383.
9. Hardin D.S. Pharmacotherapy of diabetes in cystic fibrosis patients. Expert Opin Pharmacother 2010, 11:771-778.
10. Friedman J.M. Leptin at 14 years of age: an ongoing story. Am J Clin Nutr 2009, 89:973S-979S.
11. Lago R., Gomez R., Lago F., Gomez-Reino J., Gualillo O. Leptin beyond body weight regulation: current concepts concerning its role in immune function and inflammation. Cell Immunol 2008, 252:139-145.
12. Cai C., Hahn B.H., Matarese G., La Cava A. Leptin in non-autoimmune inflammation. Inflamm Allergy Drug Targets 2009, 8:285-291.
13. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996, 382:250-252.
14. Lee M.J., Fried S.K. Integration of hormonal and nutrient signals that regulate leptin synthesis and secretion. Am J Physiol Endocrinol Metab 2009, 296:E1230-E1238.
15. Canadian Diabetes Association. 2008 Clinical Practice Guidelines. Canadian Diabetes Association Online: Canadian Diabetes Association; [Updated 2008/09, Cited 2010/09/20]. Available from: http://www.diabetes.ca/files/cpg2008/cpg-2008.pdf.
16. Cohen R.I., Tsang D., Koenig S., Wilson D., McCloskey T., Chandra S. Plasma ghrelin and leptin in adult cystic fibrosis patients. J Cyst Fibros 2008, 7:398-402.
17. Ziai S., Belson L., Coderre L., Berthiaume Y., Rabasa-Lhoret R. Insulin secretion indices in cystic fibrosis. J Cyst Fibros 2011, 10:145.
18. Milla C.E. Association of nutritional status and pulmonary function in children with cystic fibrosis. Curr Opin Pulm Med 2004, 10:505-509.
19. Arumugam R., LeBlanc A., Seilheimer D.K., Hardin D.S. Serum leptin and IGF-I levels in cystic fibrosis. Endocr Res 1998, 24:247-257.
20. Schmitt-Grohe S., Hippe V., Igel M., von Bergmann K., Posselt H.G., Krahl A., et al. Serum leptin and cytokines in whole blood in relation to clinical and nutritional status in cystic fibrosis. J Pediatr Gastroenterol Nutr 2006, 43:228-233.
21. Stylianou C., Galli-Tsinopoulou A., Koliakos G., Fotoulaki M., Nousia-Arvanitakis S. Ghrelin and leptin levels in young adults with cystic fibrosis: relationship with body fat. J Cyst Fibros 2007, 6:293-296.
22. Ahmed M.L., Ong K.K., Thomson A.H., Dunger D.B. Reduced gains in fat and fat-free mass, and elevated leptin levels in children and adolescents with cystic fibrosis. Acta Paediatr 2004, 93:1185-1191.
23. Boguszewski M.C., Kamoi T.O., Bento Radominski R., Boguszewski C.L., Rosberg S., Filho N.A., et al. Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis. Horm Res 2007, 67:250-256.
24. Morris D.L., Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009, 297:E1247-E1259.
25. Faraj M., Beauregard G., Tardif A., Loizon E., Godbout A., Cianflone K., et al. Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men. Diabetes Metab 2008, 34(4 Pt 1):334-342.